All Activity

Great post. The particular submit has an effect on plenty of important difficulties individuals community. We all can't be uninvolved to be able to these kinds of difficulties. This kind of submit offers guidelines and also principles. Extremely useful and also sensible. Apartamentos Turísticos Nerja

Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. slot 4d Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. spaceman Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. miototo Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. slot toto Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. togel sgp

Fantastic Put up, I'm sure a giant believer through post feed-back concerning webpages towards allow the blog page consultants recognise that they’ve further a specific thing positive towards the web! 火災保険 × 申請しないと損

Code promo 1Win tours gratuits 2026 : 1W2026VIP, les joueurs peuvent souvent recevoir des tours gratuits, un pourcentage augmenté du bonus sur dépôt et d'autres bonus. 1Win créditera automatiquement votre compte bonus avec un bonus de 500 %. Le bonus sans dépôt est l'une des récompenses les plus recherchées dans les paris sportifs en ligne et les casinos. Ce type de promotion permet aux joueurs de recevoir de l'argent gratuit, des tours gratuits ou des crédits de paris sans effectuer un dépôt initial code promo 1win gratuit aujourd hui

Pour aider à atténuer le risque, 1Win offre un bonus Cashback sur les paris perdus, où un pourcentage des pertes encourues — particulièrement sur les accumulateurs ou les paris à enjeux élevés — est remboursé soit sous forme de fonds bonus soit en argent réel. Ce bonus fournit un filet de sécurité qui adoucit l'impact d'un pari infructueux, encourageant les joueurs à continuer à parier en réduisant le risque financier associé à chaque pari code promo 1win abidjan

With thanks to get furnishing recently available posts in connection with the dilemma, I actually look ahead to learn extra. 火災保険 申請方法

Patterns become familiar, reactions Slice Master grow smoother, and timing feels more instinctive. Improvement feels earned through understanding rather than repetition alone.

A Florida campaign seeking to put marijuana legalization on the state’s 2026 ballot has filed a new lawsuit against state officials, alleging that they improperly directed the invalidation of about 71,000 signatures as a turn-in deadline quickly approaches. Smart & Safe Florida has been fighting several legal battles this cycle to ensure that its initiative is able to qualify for ballot placement. The latest lawsuit, filed in the Leon County circuit court on Monday, claims Secretary of State Cord Byrd (R) directed county election officials to invalidate about 42,000 signatures from so-called “inactive” voters and roughly 29,000 signatures collected by out-of-state petitioners. This comes after another court upheld a previous decision to strike about 200,000 signatures that the state said were invalid because the petitions didn’t include the full text of the proposed initiative. The campaign contested the legal interpretation, but it declined to appeal the decision based on their confidence they’d collected enough signatures to make up the difference. Now, with a February 1 deadline to submit 880,062 valid signatures just about a month away, Smart & Safe Florida is signaling that the additional invalidations could jeopardize their chances of making the ballot. Currently, the state has validated 675,307 signatures. “Time is of the essence,” the new lawsuit says, according to The News Service of Florida. “The Florida secretary of state has issued two unlawful directives that, unless stopped, will invalidate the citizen initiative petitions signed by more than 70,000 registered voters.” With respect to the “inactive” voters, the term refers to those who are registered but for whom mail is marked as undeliverable, resulting in their addresses being considered unconfirmed. This group can become unregistered if they don’t vote in two consecutive general elections. “The absurd result of the secretary’s directive is that ‘inactive’ voters can vote for the proposed amendment but cannot have their petitions counted to place the proposed amendment on the ballot to vote for it,” the lawsuit says. The out-of-state petitioner issue, meanwhile, is about the enforcement of a law passed earlier this year barring non-Florida residents from collecting signatures. Amid legal challenges, a federal court issued an injunction blocking its enforcement for about two months before that injunction was stayed by another judge. Smart & Safe Florida is arguing that signatures collected during the injunction window should not be invalidated, as they were lawfully obtained while the law was not in effect. Meanwhile, earlier this month, Florida’s attorney general asked the state Supreme Court to review the constitutionality of the legalization initiative. The court accepted the request and set a schedule for state officials and the cannabis campaign to file briefs next month. The campaign said last month that it’d collected more than one million signatures to put the cannabis measure on the ballot, but it’s also challenged officials at the state Supreme Court level over delays the certification process, arguing that the review of the ballot content and summary should have moving forward months ago when it reached an initial signature threshold. The state then agreed to move forward with the processing. Florida Gov. Ron DeSantis (R) campaigned heavily against an earlier version of the legalization proposal, which received a majority of voters last year but not enough to meet the 60 percent threshold required to pass a constitutional amendment. Former Attorney General Ashley Moody (R) unsuccessfully contested the prior initiative in the courts. In March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to Gov. Ron DeSantis (R). The money was used to fight against a citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. The lawmakers’ letter followed allegations that a $10 million donation from a state legal settlement was improperly made to the Hope Florida Foundation, which later sent the money to two political nonprofits, which in turn sent $8.5 million to a campaign opposing Amendment 3. The governor said in February that the newest marijuana legalization measure is in “big time trouble” with the state Supreme Court, predicting it will be blocked from going before voters next year. “There’s a lot of different perspectives on on marijuana,” DeSantis said. “It should not be in our Constitution. If you feel strongly about it, you have elections for the legislature. Go back candidates that you believe will be able to deliver what your vision is on that.” “But when you put these things in the Constitution—and I think, I mean, the way they wrote, there’s all kinds of things going on in here. I think it’s going to have big time trouble getting through the Florida Supreme Court,” he said. The latest initiative was filed with the secretary of state’s office just months after the initial version failed during the November 2024 election—despite an endorsement from President Donald Trump. Smart & Safe Florida is hoping the revised version will succeed in 2026. The campaign—which in the last election cycle received tens of millions of dollars from cannabis industry stakeholders, principally the multi-state operator Trulieve—incorporated certain changes into the new version that seem responsive to criticism opponents raised during the 2024 push. For example, it now specifically states that the “smoking and vaping of marijuana in any public place is prohibited.”Another section asserts that the legislature would need to approve rules dealing with the “regulation of the time, place, and manner of the public consumption of marijuana.” Last year, the governor accurately predicted that the 2024 cannabis measure from the campaign would survive a legal challenge from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome. While there’s uncertainty around how the state’s highest court will navigate the measure, a poll released in February showed overwhelming bipartisan voter support for the reform—with 67 percent of Florida voters backing legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background, a recent poll from a Trump-affiliated research firm found that nearly 9 in 10 Florida voters say they should have the right to decide to legalize marijuana in the state. Meanwhile, a pro-legalization GOP state lawmaker recently filed a bill to amend state law to codify that the public use of marijuana is prohibited. Rep. Alex Andrade (R), the sponsor, said earlier this year that embracing cannabis reform is a way for the Republican party to secure more votes from young people. Separately, Florida medical marijuana officials are actively revoking the registrations of patients and caregivers with drug-related criminal records. The policy is part of broad budget legislation signed into law earlier this year by DeSantis. The provisions in question direct the state Department of Health (DOH) to cancel registrations of medical marijuana patients and caregivers if they’re convicted of—or plead guilty or no contest to—criminal drug charges. Photo courtesy of Mike Latimer. The post Florida Marijuana Campaign Sues State Over Invalidation Of 71,000 Signatures With Turn-In Deadline Weeks Away appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Colorado’s world-class marijuana industry drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction.” By Elyse Apel, The Center Square In 2025, Coloradans spent upwards of $1 billion on legal marijuana. That generated almost $200 million in tax and fee revenue for the state, according to monthly data published by the Colorado Department of Revenue. By the end of the year, the department anticipates Colorado will surpass $1 billion in tax and fee revenue on marijuana sales. “Colorado’s world-class marijuana industry drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction,” Colorado Gov. Jared Polis (D) posted on x.com. “This important milestone is one that our state can continue to build on.” Colorado has long been on the forefront of the legalization of marijuana. In 2012, it was the first state in the United States to approve the sale of licensed recreational marijuana. Since then, the state has brought in more than $3 billion dollars in tax and fee revenue from marijuana, while marijuana sales have topped nearly $18 billion. Heralded as a major revenue source for the state, its tax revenue has been used over the years to help fund infrastructure projects and public schools. Colorado’s world-class marijuana industry drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction. This important milestone is one that our state can continue to build on. pic.twitter.com/BWvJxscLMG — Governor Jared Polis (@GovofCO) December 26, 2025 Currently, the state’s sales tax sits at 2.9 percent, the state retail marijuana sales tax at 15 percent, and the state retail marijuana excise tax at 15 percent. Federal policy has been slowly changing to reflect the legalization of marijuana in the majority of states. Just earlier this month, President Donald Trump signed an executive order on reclassifying marijuana from a Schedule I drug to a Schedule III drug. This signals a significant shift in the federal government’s stance on marijuana. “Decades of federal drug control policy have neglected marijuana’s medical uses,” the order said. “The federal government’s long delay in recognizing the medical use of marijuana does not serve the Americans who report health benefits from the medical use of marijuana to ease chronic pain and other various medically recognized ailments.” Polis applauded this decision, calling it “long overdue.” “It’s far past time for the federal government to catch up to Colorado and many other states and get rid of arcane federal policies on cannabis that aren’t based in reality and hurt Colorado small businesses and public safety,” he said. “For years Colorado has been a national leader in smart and safe cannabis policy that has virtually eliminated illegal markets, ensured safe use, and generated over a billion dollars for education. Colorado’s cannabis industry is the gold standard ensuring that products are safe and regulated.” Not everyone is happy with Trump’s order though, as concerns especially grow about high-potency THC products. “The Trump administration has declared a literal war on drugs, saying that fentanyl is a ‘weapon of mass destruction,’ while at the same time potentially making marijuana more accessible by loosening federal restrictions,” Tony Perkins, president of the Family Research Council, posted in response to the order on x.com. “Colorado, which legalized marijuana in 2012, has become a case study of the consequences: an increase in traffic deaths, mental health concerns, and emergency room visits, workplace safety issues, and a growth in the black market.” Complete data on Colorado marijuana sales from the year will be available in February. This story was first published by The Center Square. The post Colorado Governor Touts State’s $1 Billion In Legal Marijuana Sales This Year appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Laws aimed at preventing marijuana-impaired driving in almost 20 states are causing innocent people who show no signs of impairment to be criminalized and imprisoned for allegedly operating vehicles while under the influence, a new government-funded study shows. Lawmakers and regulators aiming to reduce drug-impaired driving have long sought to apply a familiar strategy from alcohol enforcement: setting a numerical limit of THC in the bloodstream beyond which a driver is presumed to be impaired, commonly referred to as a “per se” amount. But the new study suggests that approach may be badly misaligned with the science related to impairment from cannabis, the components and metabolites of which can remain in the body day or weeks after use—when impairment is no longer an issue. “Many regular users of cannabis exceed zero tolerance and per se THC cutpoint concentrations days after their last use, risking legal consequences despite no evidence of impairment,” the study, which was published in the scientific journal Clinical Chemistry and partially funded by the National Institutes of Health and the State of California, found. The findings echo earlier research showing weak or inconsistent links between THC blood levels and crash risk. Large epidemiological studies have found that while marijuana use may slightly increase collision risk, the effect is far smaller than that of alcohol use. “One of the primary problems with using THC concentrations in per se legislation is that the pharmacokinetics of THC are much different from ethanol,” the researchers wrote. The authors noted that alcohol generally cannot be detected 1 to 2 days after last ingestion, whereas THC can be measured up to 30 days after last use because of its lipophilic nature. To generate the data, researchers studied 190 heavy consumers who were instructed to abstain for 48 hours. Following that several day period, the participants’ blood THC concentrations were measured both before and after cannabis consumption to establish baselines. They were also observed using a driving simulator. “Current cannabis blood concentrations used to identify impaired drivers could land innocent people in jail,” the Association for Diagnostics & Laboratory Medicine, which publishes the journal that the study appeared in, said in a press release. “Cannabis blood limit laws lack scientific credibility and are not an accurate determinant of when drivers should face criminal charges or not.” The authors of the study concluded that “more work needs to be done to address how to best identify drivers who are under the influence of cannabis and are unsafe to drive.” “Despite evidence showing no correlation between the detection of THC in the blood and driving impairment, 6 states in the United States have per se laws using 2 or 5 ng/mL of THC as the cut-off point for driving under the influence of cannabis, while 12 have a zero-tolerance law,” the journal’s press release says. The authors, affiliated with the University of California, San Diego and the Center for Medicinal Cannabis Research cautioned that additional research is needed, saying “at present, the best protocol is a combination of observations in the field and toxicology testing.” A separate study last year found “no support that marijuana legalization increased tolerant behaviors and attitudes toward driving after marijuana use.” Authored by researchers at Nationwide Children’s Hospital and Ohio State University, the study used data from a national traffic safety survey. Earlier this year, President Donald Trump’s now-confirmed nominee to lead a key federal traffic safety agency said he’s prepared to “double down” on increasing awareness about the risk of marijuana-impaired driving in partnership with the White House. The post Marijuana Users Are Being Unjustly Jailed For Allegedly Driving Under The Influence, Government-Funded Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

При создании аккаунта на официальном сайте 1xBet есть поле «Промокод» — туда нужно ввести специальный код как ввести промокод в 1xbet

California officials have awarded nearly $30 million in grants for marijuana-focused academic research projects. The government-funded studies will focus on issues such as cannabis use by older people, the effects of THC beverages, the therapeutic potential of novel cannabinoids, how compounds like terpenes affect product flavoring, tribal participation in the legal market and the environmental impact of marijuana licensing programs. This marks the third round of grants delivered through the program—which is funded by marijuana tax revenue—raising the total distributions to about $80 million. The Department of Cannabis Control (DCC) said it prioritized proposals in research areas including educational methods of improving public health and safety, crop yields, state and local marijuana policies, consumer preferences, environmental sustainability and other topics. “All research findings will be made available at no cost to the public to support broad access to rigorous, science-backed research while contributing to the national understanding of cannabis,” the department said in a press release on Monday. “DCC received 149 proposals,” it said. “Funding decisions were based on researchers demonstrating strong scientific methodologies, the potential of their research to improve public understanding of cannabis and its effects, and to inform future policymaking.” Here are some examples of grant awardees and their research initiatives: UC San Diego: Cannabis Use and Product Selection Among Older Adults. This study seeks understanding of how older adults weigh product features like potency, cost, and safety when purchasing cannabis. Findings will inform labeling, education, and retail strategies to improve consumer safety and support evidence-based cannabis policy for aging populations. ($643,428) UC San Francisco: Clinical pharmacology of commercially available THC-infused beverages. This study will measure THC absorption, onset, and duration across multiple infused-beverage formulations under real-world consumption conditions. Results will inform product safety standards, labeling accuracy, and consumer guidance for low-dose beverage products to minimize impairment risks. ($1,975,523.03) UC Davis: Pathways to Partnership with the Tribal Cannabis Market. This study will examine California’s tribal cannabis markets and identify models for tribal–state collaboration. The project will produce regulatory templates and partnership pathways to enhance consumer safety, environmental sustainability, and economic opportunities while respecting tribal sovereignty. ($698,537) UC San Francisco: Cannabinoids and the brain: Focused investigations of therapeutic application and early-life risk. This project will examine how exposure to specific cannabinoids affects brain development, neuroinflammation, and therapeutic pathways. The work will clarify safe dosage thresholds and long-term neurological risks, advancing cannabinoid-based medicine and public health protection. ($1,993,986.41) UC Los Angeles: Cannabinoid Therapeutics: Synthesis, Binding, Safety, and Computations. This project will study and characterize novel cannabinoids with therapeutic potential. ($2,000,000) UC San Diego: Price and Tax Trends and Their Effects on Cannabis Sales: Evidence from Multi-State Retail Scanner Data. Using comprehensive retail scanner data across 20+ U.S. states, this project will analyze consumer responsiveness to price changes and tax rates, providing actionable insights to guide equitable, health-oriented taxation policies. ($1,219,052) UC Berkeley: Cannabis Crop Yields: Survey & Remote Sensing. This project will estimate cannabis crop yield variability across indoor, outdoor, and mixed-light cultivation systems. The resulting models will improve crop-production estimates and inform regulatory oversight and market forecasting for California’s legal cannabis sector. ($1,807,977) UC Los Angeles: Characterization of Naturally Occurring Organoleptic Compounds for Inhalable Cannabis Regulation. This study will build a Flower Flavor-Compound Reference Dataset defining natural terpene concentration ranges to distinguish authentic plant flavors from prohibited additives, supporting DCC policy and consumer safety. ($1,234,746) San Diego State: Pesticide and Allergen Exposure Among Cannabis Workers: An Occupational Health Study. Through a community-based field study of 150 participants, this research uses silicone wristbands for passive chemical sampling and advanced analysis to assess pesticide and terpene exposure among cannabis workers across cultivation types. Results will provide the first comprehensive exposure profile for California’s cannabis workforce, guiding occupational health protections and regulatory enforcement. ($1,157,196) UC Berkeley: Assessing the Environmental Benefits of Cannabis Licensure. This study compares licensed and unlicensed cultivation sites to quantify improvements in water, habitat, and pesticide management following licensure. ($731,754) One of the earlier rounds, in 2023, focused on studies investigating novel cannabinoids like delta-8 THC, the genetics of “legacy” strains from the state and monopolies and unfair competition in the market. Meanwhile, in May, the Governor’s Office of Business and Economic Development (GO-Biz) announced the recipients of over $52 million in community reinvestment grants to nonprofits and local health departments, also funded by marijuana tax revenue. That marked the seventh round of cannabis-funded California Community Reinvestment Grants (CalCRG) under the state program. Legalization in California has created a number of new grant programs aimed at addressing the consequences of marijuana prohibition and attempting to nurture a strong, well-regulated legal industry. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, in October the governor of California vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.” Also that month, Gov. Gavin Newsom (D) signed a bill aimed at streamlining research on marijuana and psychedelics. In September, the governor also signed legislation into law to put a pause on a recently enacted tax hike on marijuana products. The post California Officials Award $30 Million In Marijuana Revenue To Support Research On THC Drinks, Terpenes And Tribal Cannabis Sales appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

As 2025 comes to a close, the cannabis world is reflecting on the sometimes dizzying series of political, legal and cultural shifts that took place this year—and looking ahead to further developments that advocates and industry stakeholders will be navigating in the new year. Top of mind, of course, is President Donald Trump’s executive order this month directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), marking perhaps the most significant administrative cannabis action in U.S. history. But from the White House to the U.S. Supreme Court to state legislatures across the country, there were additional meaningful marijuana developments this year. That includes the upending of key provisions of federal law that had legalized hemp and its derivatives. What 2026 will bring is yet to be seen. Many eyes will be focused on how the Justice Department approaches the president’s rescheduling directive, but some see opportunities for further reform—with optimism that there’s momentum to see through a bipartisan banking bill, for example. And hopes are high that additional states could legalize cannabis in 2026—though advocates are also preparing to fight prohibitionist efforts to roll back wins that have already been achieved in other states. Looking back at 2025, here are the top marijuana moments: Trump signs marijuana rescheduling executive order After campaigning on a promise to reschedule marijuana ahead of his second term–and months of relative silence on cannabis issues after taking office—Trump in December signed an executive order directing the attorney general to expeditiously complete the process of moving cannabis to Schedule III. The reform hasn’t been finalized yet, but if it is, the policy change would mark one of the most substantial changes to federal marijuana laws since its prohibition over half a century ago. Rescheduling wouldn’t legalize the plant, but it would recognize its medical value, allow marijuana businesses to take federal tax deductions and loosen certain research barriers. In addition to rescheduling, Trump administration announces policy to expand access to CBD Trump’s executive order also urged Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients. If lawmakers do so, it could mitigate some concerns in the sector about a recent spending bill the president signed with provisions that would broadly ban consumable hemp products. A further redefinition of hemp would be part of a novel proposal to allow Medicare recipients to access non-intoxicating CBD that’d be covered under the federal health care plan. U.S. Supreme Court declines to take landmark case challenging prohibition Advocates and stakeholders were handed a defeat from the Supreme Court in December after justices declined to accept a case challenging the constitutionality of federal marijuana prohibition—an issue that even one of the bench’s more conservative members, Justice Clarance Thomas, had previously argued must be resolved amid the state legalization movement. Massachusetts-based marijuana businesses had asked the court to take their case because they argued that federal law unconstitutionally prohibits intrastate cannabis activity, contravening the Commerce Clause. Justices weigh federal gun ban for marijuana consumers In October, meanwhile, the Supreme Court agreed to hear a case on the constitutionality of a federal law prohibiting people who use marijuana or other drugs from buying or possessing firearms. The Trump administration has argued that the policy “targets a category of persons who pose a clear danger of misusing firearm” and should be upheld. Trump signs spending bill with hemp ban provisions In November, the president signed appropriations legislation that includes provisions to ban most consumable hemp products that have proliferated since the crop was legalized under the 2018 Farm Bill that Trump signed during his first term in office. The hemp components won’t be implemented until one year after enactment, however, and stakeholders and certain lawmakers say that window could provide an opportunity to advance legislation to create an alternative regulatory model for cannabinoid products. Congressional lawmakers file cannabis bills and hold hearings on various marijuana issues A slew of cannabis bills were filed or refiled for the 119th Congress in 2025, including those that would federally legalize marijuana, take steps to prepare for the eventual end of prohibition, stop the implementation of a federal hemp THC product ban, prevent people from using federal financial assistance at marijuana dispensaries, protect military veterans from losing government benefits for using medical cannabis in compliance with state law and more. None of those measures advanced to enactment, though lawmakers did approve amendments to a spending bill that would have authorized U.S. Department of Veterans Affairs (VA) doctors to issue medical marijuana recommendations to military veterans and support psychedelics research and access. Even though versions of the veterans’ medical cannabis amendment were approved by both the House of Representatives and Senate, the reform was stripped out of a final spending bill sent to the president. And while there’s been disappointment about the lack of progress on cannabis industry banking issues, a Senate subcommittee did take up the subject at a hearing in December that featured a former state marijuana regulator as a witness. Trump administration rescinds Biden-era marijuana enforcement guidance The Trump administration quietly rescinded guidance implemented under former President Joe Biden that ordered U.S. prosecutors to be “extremely cautious” about how to handle cannabis cases. In November, the U.S. Attorney’s Office for the District of Wyoming disclosed that the guidance was rescinded in September, and it said cases involving marijuana would consequently be “rigorously” enforced on federal land. Federal immigration officials raid California marijuana business Marijuana farms operated by a major state-licensed business in California were raided by federal officials in July. The action didn’t appear to be a targeted effort by the federal government against the state-legal cannabis industry specifically, as other reports indicated that Immigration and Customs Enforcement (ICE) agents had been involved in numerous enforcement actions in the area at the time. American medical cannabis patient released from Russian prison after possession conviction An American who was released from a Russian prison over marijuana possession he obtained as a lawful medical cannabis patient in Pennsylvania was among President Donald Trump’s invited guests at a speech before a joint session Congress on in March. Marc Fogel—who was serving a 14-year sentence in Russian after being convicted of “drug smuggling” over possession of a half-ounce of cannabis and whose release was secured as part of a prisoner swap—was in attendance at the president’s speech on Capitol Hill. Vice President JD Vance and U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. participate in conference with psychedelics panel Vance, Kennedy, Food and Drug Administration (FDA) Commissioner Marty Makary and other top Trump administration officials attended a “Make America Healthy Again” summit that featured a session on the therapeutic potential of psychedelics. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services (CMS), and Katie Miller, wife of Trump adviser Stephen Miller, were also among those who attended the event, which was meant to broadly showcase the MAHA agenda and areas of innovation in public health. State-level legalization efforts gain momentum Although no additional states enacted cannabis legalization laws in 2025, reform legislation did advance—demonstrating momentum that advocates hope to build upon in 2026. The Pennsylvania House of Representatives in March passed a bill to legalize marijuana sales through a novel system of state-owned dispensaries, but it was rejected in the GOP-controlled Senate. Two Hawaii Senate panels in February approved a broad bill that would legalize adult-use marijuana and bring together hemp and cannabis regulation under a single state agency. Also, the full Senate gave approval to a bill that would, among other changes, allow healthcare providers to recommend cannabis to treat any condition they believe it would benefit. The New Hampshire House of Representatives approved bills to legalize marijuana, decriminalize the use and possession of psilocybin by adults and double the amount of medical cannabis that state-registered patients can purchase and possess. The Virginia legislature approved legislation to legalize adult-use cannabis sales, only to have it once again vetoed by the governor. Marijuana sales launch in Delaware, Minnesota and Kentucky Adult-use marijuana sales began in Delaware and Minnesota in 2025, while medical cannabis dispensaries opened their doors in Kentucky. States impose hemp bans amid concerns over intoxicating cannabinoid products As congressional lawmakers moved to recriminalize certain hemp products, red and blue states—from Texas to Ohio to California—took steps on their own to restrict the sale of consumable cannabinoids. Virginia elects pro-cannabis governor as legislative commission unveils legalization plan Efforts to legalize adult-use marijuana sales in Virginia got a boost with the election of Abigail Spanberger as the state’s next governor. And the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market subsequently unveiled a much-anticipated proposal to legalize recreational marijuana sales that it is recommending lawmakers pass during the 2026 session. Florida campaign makes another run to legalize adult-use marijuana through the ballot The campaign Smart & Safe Florida filed a new cannabis legalization initiative that they hope will go before voters next November. And after collecting what they estimated to be more than one million signatures to secure ballot placement amid litigation, Florida’s attorney general asked the state Supreme Court to review the constitutionality of the proposal. Anti-marijuana activists plot to undermine state legalization laws In three states—Arizona, Maine and Massachusetts—prohibitionist activists have made moves to put initiatives on the ballot next year to roll back key components of adult-use legalization laws, focusing largely on the elimination of the commercial market. More developments arise in state-level drug policy ballot campaigns An Idaho campaign unveiled a since-certified initiative to put medical marijuana legalization on the state’s 2026 ballot. In Oregon, activists withdrew a ballot proposal to legalize marijuana social consumption lounges. And in Alaska, a campaign said it failed to collect enough signatures to put an initiative to legalize certain psychedelics such as psilocybin and DMT on the ballot next year—but activists emphasized that the “work is far from over” as they shift focus to placing the reform measure before voters in 2028. New York marks milestones in marijuana market expansion After a rocky rollout of the state’s adult-use marijuana law, marred by lawsuits and regulatory complications, New York officials in November celebrated the opening of its 500th legal cannabis dispensary—touting the fact that there have been $2.3 billion in sales since the market launched, supporting an estimated 25,000 jobs across the industry. States move forward with psychedelics reform Over the summer, Texas Gov. Greg Abbott (R) signed into law a bill to create a state-backed research consortium to conduct clinical trials on ibogaine as a possible treatment for substance use disorders and other mental health conditions. And in Arizona, officials approved and funded a first-in-the-nation clinical trial investigating the potential of whole mushroom psilocybin to treat post-traumatic stress disorder (PTSD) in first responders and military veterans. New Jersey gubernatorial election raises hopes for reform New Jersey voters elected U.S. Rep. Mikie Sherrill (D-NJ) to serve as the state’s next governor, meaning there’s now a decidedly clearer path to advancing a marijuana policy reform long awaited by consumers and advocates in the Garden State: A home grow option. Target launches pilot program for hemp beverage sales In one of the latest examples of the normalization of cannabis in mainstream commercial marketing, the retail giant Target soft launched sales of THC-infused beverages at select stores in Minnesota. Edible Arrangements offshoot embraces the hemp industry The company behind Edible Arrangements is entering the cannabis market, launching a new delivery service for hemp products. Edible Brands, best known for its line of ornate fruit arrangements, announced in March that it was expanding to start selling different kinds of edibles: hemp gummies, drinks and supplements. Photo courtesy of Philip Steffan. The post Marijuana Saw Some Big Moments In 2025—From Trump’s Rescheduling Order To State Legalization Momentum appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Texas health officials have released a set of proposed rules to regulate the state’s hemp market—including provisions related to age-gating, licensing fees, testing requirements, packaging restrictions and more in response to an executive order the governor signed in September. The proposal would also shift hemp to a total THC standard, rather than the current one that limits delta-9 THC content alone, which advocates say will eliminate some popular products from the market. Various state agencies have been taking steps to align their policies with the governor’s order, and now the Department of State Health Services (DSHS) is outlining its plan to expand and codify hemp rules in a notice published in the Texas Register on Friday. One of the more significant provisions makes it so consumable hemp products could not be sold to people under 21. That policy is already in place under an emergency rule the agency adopted in October, so officials are now seeking to finalize it. There would also be increased licensing fees for hemp businesses under the rules, which DSHS CFO Christy Havel Burton said would mean the industry “may incur economic costs” in the first five years of implementation. “Some retailers and manufacturers may incur costs associated with compliance with age verification requirements, depending on the methodology and equipment used to verify identification and to ensure minors are not sold consumable hemp products,” she said. The rule—which is open to public comment until January 26—would also prohibit transporting products containing more than 0.3 percent THC into Texas for additional processing and require hemp products to be secured in packaging that’s “tamper-evident, child-resistant and non-attractive to children.” State code would additionally be amended to explicitly prohibit labeling cannabis products in a way that misleads consumers “to believe products do not contain hemp-derived cannabinoids or are intended for medical use,” the notice says. There are also a series of more technical policy changes related to product tracking, record-keeping, recall procedures and testing requirements. While hemp businesses may incur financial costs to get into compliance with the new rule, an economic estimate included in the notice says the government would see an increase in revenue of about $202 million for the first five years after it takes effect. Timothy Stevenson, deputy commissioner of DSHS’s Consumer Protection Division, additionally said that “the public benefit will be increased public health requirements for the manufacturers, distributors, and retailers of CHPs along with prohibited availability and access of CHPs to minors.” A public hearing on the proposed rules is scheduled for January 9. Heather Fazio of the Texas Cannabis Policy Center said in an email to supporters that the rules “include some important, long-overdue consumer protections,” but she also cautioned that in other ways the proposal “raises serious concerns.” She said the fee increases for operators are “dramatic” and “would place enormous strain on small businesses, micro-businesses, and rural retailers.” The shift to a total THC standard, meanwhile, “would effectively eliminate hemp flower from the legal market,” Fazio said. “Removing regulated access to the most common and least processed hemp product does not eliminate demand—it pushes consumers into unregulated markets with no testing, no age checks, and no consumer protections,” she said. (Disclosure: Fazio supports Marijuana Moment’s work with a monthly pledge on Patreon.) After the governor issued the emergency order barring hemp sales, the Texas Alcoholic Beverage Commission (TABC) separately put forward temporary emergency rules to codify the policy change—and earlier this month it released plans to adopt an amended regulation on the issue permanently after receiving public and stakeholder input. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, state officials with the Department of Public Safety (DPS) separately conditionally approved nine new medical marijuana business licenses this month as part of a law that’s being implemented to significantly expand the state’s cannabis program. The department will issue conditional licenses to three additional dispensaries by April 2026. This represents a major change to the program, as there are currently only three dispensaries licensed to operate in Texas. DPS in October adopted additional rules to increase the number of licensed dispensaries, establishing security requirements for “satellite” locations and authorizing the revocation of licenses for certain violations. DSHS also recently finalized rules allowing doctors to recommend new qualifying conditions for cannabis patients and creating standards for allowable low-THC inhalation devices. For what it’s worth, a survey from a GOP pollster affiliated with President Donald Trump found that Texas Democratic and Republican voters are unified in their opposition to the hemp ban proposal. Image element courtesy of AnonMoos. The post Texas Officials Invite Comment On New Hemp Rules Covering Age Limits, Licensing Fees, Labeling And More appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Awesome posting, it has the such a interesting site there is listed here, keep up to date favorable deliver the results, might be backside. how does john spencer ellis help you build a sustainable business model

Looking for Arise Ragnarok Codes? Class Rerolls? Stat Resets? We got you! Updated for December 2025 Copy codes here: https://ariseragnarok.org/

Hello, this weekend is good for me, since this time i am reading this enormous informative article here at my home. https://www.aerogaga.com/

Ohio activists announced on Monday that they’ve met an initial signature requirement to launch a campaign aimed at repealing key components of a bill the governor recently signed to scale back the state’s voter-approved marijuana law and ban the sale of consumable hemp products outside of licensed cannabis dispensaries. Ohioans for Cannabis Choice said they’ve submitted a batch of 1,000 signatures to get the referendum process started. If the signatures are certified by the secretary of state, the campaign will then need to submit a total of about 250,000 signatures to make the ballot. The proposed referendum would repeal the first three core sections of SB 56, a controversial bill that Gov. Mike DeWine (R) signed into law earlier this month that he says is intended to crack down on the unregulated intoxicating hemp market. But the legislation would do more than restrict the sale of cannabinoid products to dispensaries. The law also recriminalizes certain marijuana activity that was legalized under the ballot initiative voters approved in 2023, and it’d additionally remove anti-discrimination protections for cannabis consumers that were enacted under that law. The governor additionally used his line-item veto powers to cancel a section of the bill that would have delayed the implementation of the ban on hemp beverages. “We’re saying no to SB 56 because it recriminalizes the cannabis industry,” Wesley Bryant, a petitioner with the referendum campaign who owns the cannabis company 420 Craft Beverages, said. “SB 56 is a slap in the face to voters who overwhelmingly voted to legalize cannabis in 2023.” Advocates and stakeholders strongly protested the now-enacted legislation, arguing that it undermines the will of voters who approved cannabis legalization and would effectively eradicate the state’s hemp industry, as there are low expectations that adults will opt for hemp-based products over marijuana when they visit a dispensary. The pushback inspired the newly filed referendum—but the path to successfully blocking the law is narrow. If activists reach the signature threshold by the deadline three months from now, which coincides with the same day the restrictive law is to take effect, SB 56 would not be implemented until voters got a chance to decide on the issue at the ballot. “In filing our petitions today, we are taking a stand for Ohioans against politicians in Columbus and saying no to the government overreach of SB 56,” Bryant said. A summary of the referendum states that “Sections 1, 2, and 3 of Am. Sub. S. B. No. 56 enact new provisions and amend and repeal existing provisions of the Ohio Revised Code that relate to the regulation, criminalization, and taxation of cannabis products, such as the sale, use, possession, cultivation, license, classification, transport, and manufacture of marijuana and certain hemp products.” “If a majority of the voters vote to not approve Sections 1, 2, and 3 of the Act, then the enacted changes will not take effect and the prior version of the affected laws will remain in effect,” it says. Joey Ellwood, a hemp farmer who signed the referendum petition, said “Ohioans oppose recriminalizing cannabis.” “And this is just the start,” he said. “Politicians in Columbus won’t stop until marijuana and hemp are completely illegal in Ohio again.” Andrew Greene, another petitioner who also works at a cannabis distribution center, said “these out-of-touch politicians are hellbent on recriminalizing marijuana and hemp products.” Advocates have flagged a series of concerns with the law, pointing out, for example, that it would eliminate language in statute providing anti-discrimination protections for people who lawfully use cannabis. That includes protections meant to prevent adverse actions in the context of child custody rights, the ability to qualify for organ transplants and professional licensing. It would also recriminalize possessing marijuana from any source that isn’t a state-licensed dispensary in Ohio or from a legal homegrow. As such, people could be charged with a crime for carrying cannabis they bought at a legal retailer in neighboring Michigan. Additionally, it would ban smoking cannabis at outdoor public locations such as bar patios—and it would allow landlords to prohibit vaping marijuana at rented homes. Violating that latter policy, even if it involves vaping in a person’s own backyard at a rental home, would constitute a misdemeanor offense. The legislation would also replace what had been a proposed regulatory framework for intoxicating hemp that the House had approved with a broad prohibition on sales outside marijuana dispensaries following a recent federal move to recriminalize such products. Under the law, hemp items with more than 0.4 mg of total THC per container, or those containing synthetic cannabinoids, could no longer be sold outside of a licensed marijuana dispensary setting. That would align with a recently enacted federal hemp law included in an appropriations package signed by President Donald Trump. The federal law imposing a ban on most consumable hemp products has a one-year implementation window, however, and it appears the Ohio legislation would take effect sooner. As passed by the legislature, a temporary regulatory program for hemp beverages would have stayed in place in Ohio until December 31, 2026, but that provision was vetoed by the governor. The law also includes language stipulating that, if the federal government moves to legalize hemp with higher THC content, it’s the intent of the Ohio legislature to review that policy change and consider potential state-level reforms to regulate such products. The bill signing came months after DeWine issued emergency rules prohibiting the sale of intoxicating hemp products for 90 days, with instructions to the legislature to consider permanent regulations. A county judge has enjoined the state from enforcing that policy in response to a legal challenge. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, in September, the Ohio Department of Cannabis Control (DCC) filed proposed rules to build upon the state’s marijuana legalization law, laying out plans to update regulations on labeling and packaging requirements. The proposal came weeks after Ohio medical and adult-use marijuana sales officially crossed $3 billion, data from the state Department of Commerce (DOC) shows. The state sold about $703 million in recreational cannabis in the law’s first year of implementation, according to DCC data. In March, a survey of 38 municipalities by the Ohio State University’s (OSU) Moritz College of Law found that local leaders were “unequivocally opposed” to earlier proposals that would have stripped the planned funding. Meanwhile in Ohio, adults as of June are able to buy more than double the amount of marijuana than they were under previous limits, with state officials determining that the market can sustainably supply both medical cannabis patients and adult consumers. The governor in March separately announced his desire to reallocate marijuana tax revenue to support police training, local jails and behavioral health services. He said funding police training was a top priority, even if that wasn’t included in what voters passed in 2023. Photo courtesy of Brian Shamblen. The post Ohio Activists Submit Signatures For Referendum To Block Lawmakers’ Move To Roll Back Marijuana Legalization And Restrict Hemp appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Efficiently written information. It will be profitable to anybody who utilizes it, counting me. Keep up the good work. For certain I will review out more posts day in and day out. https://www.aerogaga.com/

1xBet Promo Code Free: 1XBURN — use this promo to get a sportsbook bonus with free bets up to $130, giving you the perfect head start in online betting. The customer gets a free bet, free spins or free bonus money, while the website gets more customers today 1xbet promo code

The 1XBET promo code: 1XBURN for 150% Up To ₹66,000 and if you use it you will activate an exclusive bonus for sports betting or casino. Right now, 1xBet does not offer a no-deposit promo code. We create favourable 1xBet bonuses and promo codes that help to top up their bankroll with free spins and real money promo code 1xbet today

Your article has piqued a lot of positive interest. I can see why since you have done such a good job of making it interesting. https://www.aerogaga.com/

1xBet registration promo code: 1XBURN bestows new bettors access to a welcome incentive of 100% up to $200 for sports betting or up to $1750 + 150 free spins. This is an alphanumeric formula you can use to get a better deal. Online casinos and bookmakers use these to incentivize customers to join. These have benefits for both the platform and the customer. The customer gets a free bet, free spins or free bonus money, while the website gets more customers 1xbet promo code free spins no deposit

The 1xbet team provides a large assortment of sports disciplines in the sports betting section. You'll be able to bet on the most popular sports in India while increasing your possible bonus by 120%. You will be able to bet on the following sports disciplines 1xbet new promo code

VA gov-elect talks marijuana legislation; Poll: Bipartisan legalization support; AZ anti-cannabis ballot measure; Nurses groups cheer rescheduling Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW A new Congressional Research Service report suggests that the Department of Justice could ignore President Donald Trump’s marijuana rescheduling directive or slow the process by filing a new proposed rule on the issue instead of enacting one left over from the Biden administration. “At the time the executive order was issued, the agencies had not taken final action on the proposed rescheduling, and it remains to be seen whether and when they will do so.” Virginia Gov.-elect Abigail Spanberger (D) spoke about what she wants to see in a bill to legalize recreational marijuana sales if she’s going to sign it—including “strong labeling” provisions and directing revenue toward education. A newly filed Arizona ballot initiative would reverse the legalization of recreational marijuana sales while continuing to allow personal possession and home cultivation. A new poll shows that 53 percent of American voters support legalizing marijuana—including majorities in every political, age, race and gender demographic. The American Nurses Association and the American Association of Nurse Anesthesiology are praising President Donald Trump’s marijuana rescheduling move, saying it will open doors to expanded research on the potential health benefits of cannabis. / FEDERAL President Donald Trump reportedly planned to announce on social media that he would move to reschedule marijuana shortly after an Oval Office meeting on the topic earlier this month but White House aides urged him not to. The Congressional Research Service noted a U.S. Court of Appeals for the Fifth Circuit ruling on marijuana consumers’ gun rights. Sen. Ted Budd (R-NC) tweeted, “We cannot reindustrialize America while encouraging marijuana use. We should not be handing tax breaks to bad actors and foreign drug cartels to advertise a drug that will harm Americans.” Rep. Madeleine Dean (D-PA) tweeted, “As we face the dual mental health and addiction crises, we must expand options for care. The Freedom to Heal Act would reduce barriers for physicians to use innovative and potentially lifesaving treatments, like MDMA and psilocybin. Recovery should be possible for everyone.” / STATES Colorado Gov. Jared Polis (D) tweeted, “Colorado’s world-class marijuana industry drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction. This important milestone is one that our state can continue to build on.” Maine regulators said they don’t anticipate any changes to state marijuana laws in response to federal rescheduling. New Jersey regulators posted an update on cannabis social equity businesses. Washington State marijuana regulators launched a rules tracking tool. U.S. Virgin Islands regulators are accepting cannabis research and development applications. Missouri marijuana regulators published the latest episode of their podcast. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / SCIENCE & HEALTH A study found that “patients with cannabis use demonstrated significantly reduced risks in new-onset diagnoses of [chronic rhinosinusitis] and [functional endoscopic sinus surgery] compared to non-users.” A study’s results “support the idea that [medical marijuana] substitutes for prescription painkillers.” / ADVOCACY, OPINION & ANALYSIS An American Enterprise Institute senior fellow authored an op-ed arguing that federal marijuana rescheduling should come with a requirement to put warning labels on cannabis products. The Multidisciplinary Association for Psychedelic Studies completed a therapy training initiative supporting clinicians participating in a Department of Defense-funded study on MDMA-assisted therapy for PTSD in active-duty military personnel. The Colorado Springs Gazette editorial board criticized Gov. Jared Polis’s (D) support for marijuana reform. / BUSINESS Headset projected that moving marijuana to Schedule III will generate $268,000 per year in 280E tax penalty savings per year for the typical median cannabis retailer. / CULTURE The New York Yankees is seeking to block a cannabis apparel company’s trademark registration for products that allegedly copy the team’s logo. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Could DOJ ignore Trump’s cannabis rescheduling order? (Newsletter: December 30, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net